Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.720
-0.050 (-1.81%)
At close: Dec 20, 2024, 4:00 PM
3.000
+0.280 (10.29%)
After-hours: Dec 20, 2024, 7:05 PM EST
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $291.00 million as of December 20, 2024. Its market cap has increased by 311.02% in one year.
Market Cap
291.00M
Enterprise Value
119.81M
1-Year Change
311.02%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $291.00M, an increase of 35.67%. That is a compound annual growth rate of 3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 194.30M | 161.16% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 312.58M |
| Immutep | 309.58M |
| Silence Therapeutics | 307.84M |
| enGene Holdings | 307.74M |
| XOMA Royalty | 305.31M |
| Nyxoah | 304.33M |
| Cerus | 299.93M |
| Aldeyra Therapeutics | 297.06M |